Infant Cured of Rare Epilepsy through Innovative Gene Therapy
Baby cured of rare epilepsy syndrome after doctors inject missing gene directly into his brain
New York Post
Image: New York Post
An eight-month-old boy with WOREE syndrome, a rare genetic epilepsy, was cured after receiving an experimental gene replacement therapy directly injected into his brain. This groundbreaking treatment restores the function of the missing WWOX gene, which is crucial for neurological development.
- 01The infant was diagnosed with WOREE syndrome, caused by a defect in the WWOX gene, leading to severe epilepsy and developmental decline.
- 02The gene replacement therapy was administered through a neurosurgical procedure at Clalit-Schneider Children’s Medical Center in Israel.
- 03Professor Rami I. Aqeilan's research on the WWOX gene led to the development of this innovative therapy, which had previously shown promise in animal models.
- 04This treatment required international collaboration and special approvals from health authorities across multiple countries.
- 05The child was discharged one month post-treatment, remaining seizure-free and critically stable, marking a significant advancement in treating rare genetic epilepsies.
Advertisement
In-Article Ad
In a groundbreaking medical achievement, an eight-month-old boy has been cured of a rare epilepsy syndrome known as WOREE syndrome after receiving an experimental gene replacement therapy. The therapy involved injecting a functional copy of the missing WWOX gene directly into the infant's brain through a delicate neurosurgical procedure. Initially appearing healthy at birth, the child began experiencing severe seizures and developmental decline by six weeks old. An international team, including researchers and clinicians from Clalit-Schneider Children’s Medical Center in Israel, collaborated to develop this treatment, which required special approvals and tailored dosing for the infant. Professor Rami I. Aqeilan's research revealed the gene's critical role in neurological function, leading to the therapy's development. Following the treatment, the child remained critically stable and was discharged from the hospital without any recurring seizures. This case represents a significant step forward in the treatment of rare genetic epilepsies, showcasing the potential of fundamental research to lead to innovative therapies.
Advertisement
In-Article Ad
This treatment could pave the way for new therapies for children with rare genetic conditions, potentially saving lives and improving quality of life.
Advertisement
In-Article Ad
Reader Poll
What do you think about gene replacement therapies for genetic disorders?
Connecting to poll...
Read the original article
Visit the source for the complete story.